Abstract
AbstractBackgroundHepatitis C virus (HCV) elimination requires a thorough understanding of the care cascade. A direct-acting-antiviral (DAA)-era description of the care cascade has not been undertaken in Ontario, Canada. Our primary objective was to describe the current population-level care cascade in the general Ontario population and among key risk-groups — baby-boomers, immigrants, and individuals experiencing residential instability. The secondary objective was to identify predictors of engagement.MethodsWe conducted a population-based cohort study of Ontario residents undergoing HCV testing between January 1, 1999, and December 31, 2018, and mapped the care cascade [antibody diagnosed, RNA tested, RNA positive, genotyped, treated, achieved sustained virologic response (SVR), reinfected/relapsed] as of December 31, 2018. The cascade was stratified by risk groups. Cause-specific hazard modeling was used to identify demographic, and socioeconomic predictors of engagement with key steps of the cascade.ResultsAmong 108,428 Ontario resident living with an HCV antibody diagnosis, 88% received confirmatory RNA testing; of these, 62% tested positive and 94% of positive tests were genotyped. Of those with confirmed viremia, 53% initiated treatment and 76% of treated individuals achieved SVR, while ∼1% experienced reinfection or relapse. Males, older birth cohorts, long-term residents, those with a history of substance use disorder and social marginalisation (e.g., material deprivation, residential instability), and those initially diagnosed in the pre-DAA era exhibited lower rates of engagement with almost every step of HCV care.ConclusionsDespite DAA-era improvements, treatment initiation remains a major gap. HCV screening and linkage-to-treatment, particularly for those with a history of substance use disorder and social marginalisation, will be needed to equitably close gaps in HCV care in Ontario.
Publisher
Cold Spring Harbor Laboratory
Reference21 articles.
1. World Health Organization (WHO). “Resolution WHA67.6” (2014).
2. Viral hepatitis C cascade of care: A population-level comparison of immigrant and long-term residents;Liver International [Internet],2021
3. Hepatitis C virus infection in First Nations populations in Ontario from 2006 to 2014: a population-based retrospective cohort analysis;Canadian Medical Association Open Access Journal [Internet],2021
4. Model-based projection of health and economic effects of screening for hepatitis C in Canada;CMAJ-Open [Internet],2017
5. Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada, using population-based cohort studies;Journal of Viral Hepatitis [Internet],2020